Concepedia

Joan-En Chang-Lin

JC

Statistics

Publications

6

Citations

865

H-Index

6

Active since

2005

Affiliations

Allergan (United States)(Current)

University of California, Irvine

Joan-En Chang-Lin is an author at Allergan (United States) specializing in pharmacokinetics, medicine, and clinical pharmacology.

Publications per year

2005–2021

6

Publications

6

Pharmacokinetics and Pharmacodynamics of a Sustained-Release Dexamethasone Intravitreal Implant

Joan-En Chang-Lin, Mayssa Attar, Andrew Acheampong et al. · Investigative Ophthalmology & Visual Science · 2010 · 594 citations · Full text

, , +17

Pharmacokinetics of a Sustained-Release Dexamethasone Intravitreal Implant in Vitrectomized and Nonvitrectomized Eyes

Joan-En Chang-Lin, James A. Burke, Qing Peng et al. · Investigative Ophthalmology & Visual Science · 2011 · 202 citations

, , +17

Efficacy and Safety of Once-Daily Dapsone Gel, 7.5% for Treatment of Adolescents and Adults With Acne Vulgaris: First of Two Identically Designed, Large, Multicenter, Randomized, Vehicle-controlled Trials.

David R. Berk, Joan-En Chang-Lin, Alexandre Kaoukhov · PubMed · 2016 · 34 citations

, , +14

Characterization of active ion transport across primary rabbit corneal epithelial cell layers (RCrECL) cultured at an air-interface

Joan-En Chang-Lin, Kwang‐Jin Kim, Vincent H.L. Lee · Experimental Eye Research · 2005 · 13 citations

, , +8

Safety and Pharmacokinetics of Once-Daily Dapsone Gel, 7.5% in Patients With Moderate Acne Vulgaris.

Michael Jarratt, Terry M. Jones, Joan-En Chang-Lin et al. · PubMed · 2016 · 11 citations

, , +13

1–5 of 6